Lysbeth Bakker

View Scopus Profile

University of Groningen

Organisational unit: University

8 shared research output

Faculty of Medical Sciences/UMCG

University of Groningen

Organisational unit: Faculty

8 shared research output

Personalized medicine research institute Groningen (PRECISION)

Faculty of Medical Sciences/UMCG

Organisational unit: Research Institute

6 shared research output

Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)

Personalized medicine research institute Groningen (PRECISION)

Organisational unit: Research programme

6 shared research output

Groningen Kidney Center (GKC)

Mechanisms of Health, Aging and Disease (MoHAD)

Organisational unit: Research programme

2 shared research output

Mechanisms of Health, Aging and Disease (MoHAD)

Faculty of Medical Sciences/UMCG

Organisational unit: Research Institute

2 shared research output

Dutch Medicines Evaluation Board, Utrecht, The Netherlands.

External organisation: Unknown

3 shared research output

European Medicines Agency, Amsterdam, the Netherlands.

External organisation: Unknown

3 shared research output

Dutch Medicines Evaluation Board

External organisation: Unknown

2 shared research output

Dutch Med Evaluat Board Coll Ter Beoordeling Van

External organisation: Unknown

1 shared research output

Dutch Medicines Evaluation Board (CBG-MEB), Utrecht

External organisation: Academic Institute

1 shared research output

Lund Univ, Lund University, Dept Clin Sci Malmo, Diabet Ctr

External organisation: Unknown

1 shared research output

Norwegian medicines agency

External organisation: Government

1 shared research output

Scientific Advice Working Party atthe European Medicines Agency (EMA)

External organisation: Company

1 shared research output

Boehringer Ingelheim International GmbH, Ingelheim, Germany.

External organisation: Unknown

1 shared research output

Univ Michigan, University of Michigan System, University of Michigan, Sch Med, Dept Computat Med & Bioinformat

External organisation: Unknown

1 shared research output

Med Univ Innsbruck, Medical University of Innsbruck, Dept Internal Med Nephrol & Hyperten 4

External organisation: Unknown

1 shared research output

ICaR VU, VU University Amsterdam, VU University Amsterdam, VU Med Ctr, Inst Cardiovasc Res

External organisation: Unknown

1 shared research output

Univ Michigan, University of Michigan, University of Michigan System, Sch Med, Dept Internal Med, Div Nephrol

External organisation: Unknown

1 shared research output

Comprehensive Health Reserach Centre (CHRC), Departamento de Ciências Médicas e da Saúde, Escola de Saúde e Desenvolvimento Humano, Universidade de Évora, Évora, Portugal

External organisation: Academic Institute

1 shared research output

AstraZeneca, Gaithersburg, MD, United States of America.

External organisation: Unknown

1 shared research output

Associação Protetora Dos Diabéticos de Portugal, Lisboa, Portugal

External organisation: Academic Institute

1 shared research output

University of Groningen, University Medical Centre Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.

External organisation: Unknown

1 shared research output

European Med Agcy EMA

External organisation: Unknown

1 shared research output

Dutch Med Evaluat Board

External organisation: Unknown

1 shared research output

Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands. [email protected].

External organisation: Unknown

1 shared research output

University of Dublin, Trinity College, Dublin, Ireland

External organisation: Academic Institute

1 shared research output

Lysbeth Bakker, MSc

Network

University of Groningen

Faculty of Medical Sciences/UMCG

Personalized medicine research institute Groningen (PRECISION)

Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)

Groningen Kidney Center (GKC)

Mechanisms of Health, Aging and Disease (MoHAD)

Dutch Medicines Evaluation Board, Utrecht, The Netherlands.

European Medicines Agency, Amsterdam, the Netherlands.

Dutch Medicines Evaluation Board

Dutch Med Evaluat Board Coll Ter Beoordeling Van

Dutch Medicines Evaluation Board (CBG-MEB), Utrecht

Lund Univ, Lund University, Dept Clin Sci Malmo, Diabet Ctr

Norwegian medicines agency

Scientific Advice Working Party atthe European Medicines Agency (EMA)

Boehringer Ingelheim International GmbH, Ingelheim, Germany.

Univ Michigan, University of Michigan System, University of Michigan, Sch Med, Dept Computat Med & Bioinformat

Med Univ Innsbruck, Medical University of Innsbruck, Dept Internal Med Nephrol & Hyperten 4

ICaR VU, VU University Amsterdam, VU University Amsterdam, VU Med Ctr, Inst Cardiovasc Res

Univ Michigan, University of Michigan, University of Michigan System, Sch Med, Dept Internal Med, Div Nephrol

Comprehensive Health Reserach Centre (CHRC), Departamento de Ciências Médicas e da Saúde, Escola de Saúde e Desenvolvimento Humano, Universidade de Évora, Évora, Portugal

AstraZeneca, Gaithersburg, MD, United States of America.

Associação Protetora Dos Diabéticos de Portugal, Lisboa, Portugal

University of Groningen, University Medical Centre Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.

European Med Agcy EMA

Dutch Med Evaluat Board

Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands. [email protected].

University of Dublin, Trinity College, Dublin, Ireland